These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3479296)

  • 21. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
    Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative pharmacokinetics of ciprofloxacin and ofloxacin in cystic fibrosis patients.
    Pedersen SS; Jensen T; Hvidberg EF
    J Antimicrob Chemother; 1987 Oct; 20(4):575-83. PubMed ID: 3479419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral bioavailability of phenobarbital: a comparison of a solution in Myvacet 9-08, a suspension, and a tablet.
    Yska JP; Essink GW; Bosch FH; Lankhaar G; van Sorge AA
    Pharm World Sci; 2000 Apr; 22(2):67-71. PubMed ID: 10849926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A preliminary report on the pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in patients with chronic renal failure.
    White LO; MacGowan AP; Lovering AM; Reeves DS; Mackay IG
    Drugs; 1987; 34 Suppl 1():56-61. PubMed ID: 3481329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension.
    Shah A; Liu MC; Vaughan D; Heller AH
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():49-54. PubMed ID: 10225572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penetration of ofloxacin from blood to sputum.
    Davies BI; Maesen FP; Geraedts WH; Baur C
    Drugs; 1987; 34 Suppl 1():26-32. PubMed ID: 3481324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers.
    Kanjanawart S; Gaysonsiri D; Phunikom K; Simasathiansopon S; Tangsucharit P; Vannaprasaht S; Kaewkamson T; Tassaneeyakul W
    Int J Clin Pharmacol Ther; 2013 Mar; 51(3):249-54. PubMed ID: 23357835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of a single oral dose of ofloxacin in patients with renal failure.
    Nawishy S; Moukhtar I; Sabbour M
    Chemioterapia; 1986 Dec; 5(6):391-3. PubMed ID: 3467875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biliary tract excretion of ofloxacin in man.
    Kazmierczak A; Pechinot A; Duez JM; Haas O; Favre JP
    Drugs; 1987; 34 Suppl 1():39-43. PubMed ID: 3481327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever.
    Bethell DB; Day NP; Dung NM; McMullin C; Loan HT; Tam DT; Minh LT; Linh NT; Dung NQ; Vinh H; MacGowan AP; White LO; White NJ
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2167-72. PubMed ID: 8878600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and bioequivalence evaluation of gliclazide/metformin combination tablet and equivalent doses of gliclazide and metformin in healthy Korean subjects.
    Cho HY; Yoon H; Lim YC; Lee YB
    Int J Clin Pharmacol Ther; 2009 Dec; 47(12):770-9. PubMed ID: 19954716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion of oral ofloxacin (HOE 280) into human prostatic tissue: assessment by an improved high-performance liquid chromatographic method.
    Claes R; Dusart Y; Dupont JC; Jeanbaptiste B; Podoor M; Douchamps J
    Infection; 1986; 14 Suppl 4():S263-5. PubMed ID: 3469159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses.
    Ferron GM; Rochdi M; Jusko WJ; Scherrmann JM
    J Clin Pharmacol; 1996 Oct; 36(10):874-83. PubMed ID: 8930773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Penetration of ofloxacin and ciprofloxacin into the aqueous humor of eyes with functioning filtering blebs: a randomized trial.
    Cantor LB; Donnenfeld E; Katz LJ; Gee WL; Finley CD; Lakhani VK; Hoop J; Flarty K
    Arch Ophthalmol; 2001 Sep; 119(9):1254-7. PubMed ID: 11545629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative bioavailability characteristics of commercial quinidine polygalacturonate and sulfate tablets.
    Dahl JR; Ueda CT; Meyers DG; Wulf BG
    DICP; 1990; 24(7-8):685-8. PubMed ID: 2375136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A non-arthropathic dose and its disposition following repeated oral administration of ofloxacin, a new quinolone antimicrobial agent, to juvenile dogs.
    Yabe K; Murakami Y; Nishida S; Sekiguchi M; Furuham K; Goryo M; Okada K
    J Vet Med Sci; 2001 Aug; 63(8):867-72. PubMed ID: 11558541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penetration of ofloxacin into bronchial secretions.
    Symonds J; Bone M; Turner A; Javaid A
    Drugs; 1987; 34 Suppl 1():33-6. PubMed ID: 3481325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.